**Question:** Which of the following statements are True or False? Please mark the correct answers with A, B, C, and D.

**Core Concept:**
Genetic polymorphisms of the P450 enzyme system, specifically CYP1A1, or chromosome fragility are associated with the development of lung cancer. Cigarette smoking increases the risk of squamous and small cell lung cancer cell types only. Varenicline is a nicotinic acetylcholine receptor partial agonist used for nicotine dependence. Low-dose, noncontrast, thin-slice helical or spiral chest CT has emerged as a possible new tool for lung cancer screening. Extrathoracic metastatic disease is found at autopsy in 20% of patients with squamous carcinoma.

**Answer Explanation:**

A. **True:** Genetic polymorphisms of the P450 enzyme system, specifically CYP1A1, or chromosome fragility are associated with the development of lung cancer.

The correct statement (A) highlights the role of genetic factors, such as polymorphisms of the P450 enzyme system, particularly CYP1A1, or chromosome fragility, in the development of lung cancer. These factors can contribute to the initiation or progression of lung cancer, making it a valid statement.

B. **False:** Cigarette smoking increases the risk of squamous and small cell lung cancer cell types only.

The statement (B) is false because cigarette smoking increases the risk of developing lung cancer across various histopathological cell types, not just squamous and small cell types. Smoking causes oxidative stress, inflammation, and genetic damage, contributing to lung cancer development in different cell types.

C. **True:** Varenicline is a nicotinic acetylcholine receptor partial agonist used for nicotine dependence treatment.

Statement (C) is true, as Varenicline, also known as Champix, is a medication approved for the treatment of nicotine dependence. It acts as a partial agonist at the nicotinic acetylcholine receptors, selectively affecting nicotine withdrawal symptoms and reducing smoking relapse rates.

D. **True:** Low-dose, non-contrast, thin-slice helical or spiral chest CT has emerged as a possible new tool for lung cancer screening.

Statement (D) is true because low-dose, non-contrast, thin-slice helical or spiral chest CT has emerged as a potential tool for lung cancer screening. This type of CT scan provides higher image resolution, reducing the radiation dose to the patient and increasing the sensitivity for detecting lung cancer at an early stage.

E. **False:** Extrathoracic lymph node involvement is seen in 20% of patients with squamous cell carcinoma.

Statement (E) is false because extrathoracic lymph node involvement is not seen in 20% of patients with squamous cell carcinoma. Instead, extrathoracic lymph node involvement is more common in larger tumors or advanced stages of squamous cell carcinoma.

**Correct Answer:** Option D (low-dose, non-contrast, thin-slice helical or spiral chest CT has emerged as a possible new tool